MAP4K3 and autoimmune disease: Consistently, the percentage of GLK-overexpressing T cells is enhanced in the peripheral blood from patients with human autoimmune diseases, including systemic lupus erythematosus (SLE) [23], rheumatoid arthritis (RA) [31], and adult-onset Still’s disease (AOSD) [32].